Chan Jenny, Perini Marcos, Fink Michael, Nikfarjam Mehrdad
University of Melbourne Department of Surgery, Austin Health, Heidelberg, Victoria, Australia.
University of Melbourne Department of Surgery, Austin Health, Heidelberg, Victoria, Australia.
HPB (Oxford). 2018 Jun;20(6):487-496. doi: 10.1016/j.hpb.2017.12.008. Epub 2018 Feb 10.
Central hepatectomy (CH) is a relatively uncommon liver resection technique. It is generally perceived as a more complex operation than extended hepatectomies (EH), with potentially higher associated morbidity. The outcomes of CH compared with EH is not well defined and there is a need to reassess.
A systematic literature search was conducted in PubMed, MEDLINE, EMBASE and Web of Science according to PRISMA guidelines for studies on the treatment of liver tumours with CH published from 1972 until February 2017. Outcomes of patients undergoing CH were assessed and compared to those undergoing EH.
18 publications including 1380 CH were included for analysis. Mortality rates after CH ranged from 0 to 9%. There were 20 (1.4%) deaths after CH and the most common cause of death was post-hepatectomy liver failure (PHLF). Morbidity rates varied between 12 and 61% and 316 (23%) post-operative events were reported. Analysis of five comparative studies showed similar mortality between CH and EH groups (OR: 0.64, 95% CI = 0.24-1.70, p = 0.37). There were significantly fewer overall post-operative complications in the CH group (OR: 0.38, 95% CI = 0.28-0.51, p < 0.001) and reduced PHLF was found in the CH group compared to EH (OR: 0.53, 95% CI = 0.29-0.98, p = 0.04). The rates of post-hepatectomy biliary complications were similar between groups (OR: 0.98, 95% CI = 0.51-1.88, p = 0.96). Mean length of stay (days) was shorter in the CH group (MD: -2.67, 95% CI = -4.93 to -0.41, p = 0.02).
CH appears to have similar post-operative mortality rates compared to EH but is associated with fewer post-operative complications, including PHLF and shorter overall length of stay.
中央肝切除术(CH)是一种相对不常见的肝切除技术。一般认为它比扩大肝切除术(EH)更为复杂,潜在相关发病率可能更高。CH与EH相比的结果尚不明确,有必要重新评估。
根据PRISMA指南,在PubMed、MEDLINE、EMBASE和科学网中对1972年至2017年2月发表的关于CH治疗肝肿瘤的研究进行系统文献检索。评估接受CH患者的结果,并与接受EH患者的结果进行比较。
纳入18篇出版物,包括1380例CH患者进行分析。CH后的死亡率在0%至9%之间。CH后有20例(1.4%)死亡,最常见的死亡原因是肝切除术后肝功能衰竭(PHLF)。发病率在12%至61%之间,报告了316例(23%)术后事件。五项比较研究的分析显示,CH组和EH组之间的死亡率相似(OR:0.64,95%CI = 0.24 - 1.70,p = 0.37)。CH组术后总体并发症明显较少(OR:0.38,95%CI = 0.28 - 0.51,p < 0.001),与EH相比,CH组PHLF降低(OR:0.53,95%CI = 0.29 - 0.98,p = 0.04)。两组肝切除术后胆系并发症发生率相似(OR:0.98,95%CI = 0.51 - 1.88,p = 0.96)。CH组的平均住院天数较短(MD:-2.67,95%CI = -4.93至-0.41,p = 0.02)。
与EH相比,CH术后死亡率似乎相似,但术后并发症较少,包括PHLF,且总体住院时间较短。